BlackRock Group’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $621M | Buy |
2,191,369
+165,228
| +8% | +$46.9M | 0.3% | 68 |
|
|
2016
Q3 | $634M | Sell |
2,026,141
-71,647
| -3% | -$22.4M | 0.32% | 58 |
|
|
2016
Q2 | $507M | Buy |
2,097,788
+86,534
| +4% | +$20.9M | 0.26% | 84 |
|
|
2016
Q1 | $524M | Sell |
2,011,254
-139,747
| -6% | -$36.4M | 0.28% | 76 |
|
|
2015
Q4 | $659M | Sell |
2,151,001
-61,261
| -3% | -$18.8M | 0.36% | 56 |
|
|
2015
Q3 | $646M | Buy |
2,212,262
+58,083
| +3% | +$16.9M | 0.38% | 54 |
|
|
2015
Q2 | $870M | Buy |
2,154,179
+10,809
| +0.5% | +$4.37M | 0.47% | 43 |
|
|
2015
Q1 | $905M | Sell |
2,143,370
-51,690
| -2% | -$21.8M | 0.49% | 44 |
|
|
2014
Q4 | $745M | Buy |
2,195,060
+25,939
| +1% | +$8.8M | 0.4% | 50 |
|
|
2014
Q3 | $718M | Sell |
2,169,121
-2,868
| -0.1% | -$949K | 0.42% | 49 |
|
|
2014
Q2 | $685M | Sell |
2,171,989
-10,683
| -0.5% | -$3.37M | 0.39% | 55 |
|
|
2014
Q1 | $668M | Buy |
2,182,672
+309,642
| +17% | +$94.7M | 0.42% | 49 |
|
|
2013
Q4 | $524M | Sell |
1,873,030
-21,899
| -1% | -$6.12M | 0.34% | 64 |
|
|
2013
Q3 | $456M | Buy |
1,894,929
+156,294
| +9% | +$37.6M | 0.31% | 71 |
|
|
2013
Q2 | $374M | Buy |
+1,738,635
| New | +$374M | 0.28% | 77 |
|